Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Aviva Geretz

Showing results (11-20 of 24) with videos related to

Pageof 3
Sort By:
HLA|June 26, 2026
Full-Length Next-Generation Sequencing of 11 HLA Loci of More Than 1000 Individuals From Clinical Cohorts in East and West AfricaYvonne V Rosario, Aviva Geretz, Lakshmi Rani Iyer, et al.
Biorxiv : the Preprint Server for Biology|December 17, 2025
Full-length next-generation sequencing of 11 HLA loci of more than 1000 individuals from clinical cohorts in East and West AfricaYvonne V Rosario, Aviva Geretz, Lakshmi Rani Iyer, et al.
Iscience|October 20, 2023
AP-1/c-Fos supports SIV and HIV-1 latency in CD4 T cells infected <i>in vivo</i>Viviana Cobos Jiménez, Aviva Geretz, Andrey Tokarev, et al.
Human Immunology|October 12, 2021
Associations of human leukocyte antigen with neutralizing antibody titers in a tetravalent dengue vaccine phase 2 efficacy trial in ThailandRasmi Thomas, Danaya Chansinghakul, Kriengsak Limkittikul, et al.
Science Translational Medicine|August 30, 2019
A vaccine-induced gene expression signature correlates with protection against SIV and HIV in multiple trialsPhilip K Ehrenberg, Shida Shangguan, Biju Issac, et al.
Elife|September 17, 2021
Monocyte-derived transcriptome signature indicates antibody-dependent cellular phagocytosis as a potential mechanism of vaccine-induced protection against HIV-1Shida Shangguan, Philip K Ehrenberg, Aviva Geretz, et al.
Cell Host & Microbe|July 16, 2022
HLA-B∗46 associates with rapid HIV disease progression in Asian cohorts and prominent differences in NK cell phenotypeShuying S Li, Andrew Hickey, Shida Shangguan, et al.
Science Translational Medicine|August 2, 2023
Single-cell transcriptomics identifies prothymosin α restriction of HIV-1 in vivoAviva Geretz, Philip K Ehrenberg, Robert J Clifford, et al.
Ebiomedicine|September 11, 2022
Long-term antiretroviral therapy initiated in acute HIV infection prevents residual dysfunction of HIV-specific CD8<sup>+</sup> T cellsHiroshi Takata, Juyeon C Kakazu, Julie L Mitchell, et al.
Cell Host & Microbe|March 4, 2021
B cell engagement with HIV-1 founder virus envelope predicts development of broadly neutralizing antibodiesSamantha M Townsley, Gina C Donofrio, Ningbo Jian, et al.
Pageof 3

Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
HLA|June 26, 2026
Full-Length Next-Generation Sequencing of 11 HLA Loci of More Than 1000 Individuals From Clinical Cohorts in East and West AfricaYvonne V Rosario, Aviva Geretz, Lakshmi Rani Iyer, et al.
Biorxiv : the Preprint Server for Biology|December 17, 2025
Full-length next-generation sequencing of 11 HLA loci of more than 1000 individuals from clinical cohorts in East and West AfricaYvonne V Rosario, Aviva Geretz, Lakshmi Rani Iyer, et al.
Iscience|October 20, 2023
AP-1/c-Fos supports SIV and HIV-1 latency in CD4 T cells infected <i>in vivo</i>Viviana Cobos Jiménez, Aviva Geretz, Andrey Tokarev, et al.
Human Immunology|October 12, 2021
Associations of human leukocyte antigen with neutralizing antibody titers in a tetravalent dengue vaccine phase 2 efficacy trial in ThailandRasmi Thomas, Danaya Chansinghakul, Kriengsak Limkittikul, et al.
Science Translational Medicine|August 30, 2019
A vaccine-induced gene expression signature correlates with protection against SIV and HIV in multiple trialsPhilip K Ehrenberg, Shida Shangguan, Biju Issac, et al.
Elife|September 17, 2021
Monocyte-derived transcriptome signature indicates antibody-dependent cellular phagocytosis as a potential mechanism of vaccine-induced protection against HIV-1Shida Shangguan, Philip K Ehrenberg, Aviva Geretz, et al.
Cell Host & Microbe|July 16, 2022
HLA-B∗46 associates with rapid HIV disease progression in Asian cohorts and prominent differences in NK cell phenotypeShuying S Li, Andrew Hickey, Shida Shangguan, et al.
Science Translational Medicine|August 2, 2023
Single-cell transcriptomics identifies prothymosin α restriction of HIV-1 in vivoAviva Geretz, Philip K Ehrenberg, Robert J Clifford, et al.
Ebiomedicine|September 11, 2022
Long-term antiretroviral therapy initiated in acute HIV infection prevents residual dysfunction of HIV-specific CD8<sup>+</sup> T cellsHiroshi Takata, Juyeon C Kakazu, Julie L Mitchell, et al.
Cell Host & Microbe|March 4, 2021
B cell engagement with HIV-1 founder virus envelope predicts development of broadly neutralizing antibodiesSamantha M Townsley, Gina C Donofrio, Ningbo Jian, et al.
Pageof 3